Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2016 - 2025)
Ionis Pharmaceuticals has reported Other Working Capital Changes over the past 13 years, most recently at -$193.2 million for Q4 2025.
- Quarterly results put Other Working Capital Changes at -$193.2 million for Q4 2025, down 1251.09% from a year ago — trailing twelve months through Dec 2025 was -$69.7 million (up 55.53% YoY), and the annual figure for FY2025 was -$69.7 million, up 55.53%.
- Other Working Capital Changes for Q4 2025 was -$193.2 million at Ionis Pharmaceuticals, down from $101.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for IONS hit a ceiling of $101.0 million in Q3 2025 and a floor of -$193.2 million in Q4 2025.
- Median Other Working Capital Changes over the past 5 years was -$7.7 million (2023), compared with a mean of -$13.4 million.
- Biggest five-year swings in Other Working Capital Changes: skyrocketed 333.95% in 2022 and later crashed 10979.43% in 2024.
- Ionis Pharmaceuticals' Other Working Capital Changes stood at -$11.2 million in 2021, then skyrocketed by 333.95% to $26.2 million in 2022, then tumbled by 116.6% to -$4.4 million in 2023, then crashed by 228.16% to -$14.3 million in 2024, then plummeted by 1251.09% to -$193.2 million in 2025.
- The last three reported values for Other Working Capital Changes were -$193.2 million (Q4 2025), $101.0 million (Q3 2025), and $10.2 million (Q2 2025) per Business Quant data.